On November 21, 2022 Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), reported that company management will participate in a fireside chat and 1×1 investor meetings at the 5th Annual Evercore ISI HealthCONx Conference being held virtually November 29 – December 1, 2022 (Press release, Crinetics Pharmaceuticals, NOV 22, 2022, https://crinetics.com/crinetics-pharmaceuticals-to-participate-in-the-5th-annual-evercore-isi-healthconx-conference/ [SID1234624332]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details of the Crinetics fireside chat are as follows:
Date & Time: November 30, 2022 at 1:00 PM (ET)
Moderator: Josh Schimmer, Research Analyst, Evercore ISI
Webcast Link: View Source
The presentation may be accessed from the Evercore ISI platform or from the Events & Presentations page in the Investors section on the Company’s website. A replay of the presentation will be accessible for 90 days.
In addition, if you are interested in arranging a virtual 1×1 meeting with members of the Crinetics management team, please contact your bank/conference representative.